Home › Triple-Negative Breast Cancer › Connecticut › East Norwalk
Triple-Negative Breast Cancer clinical trials in East Norwalk, CT
5 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around East Norwalk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
RecruitingPhase 1
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack · 19 mi away
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
RecruitingPhase 2
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack · 19 mi away
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
RecruitingPhase 2
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack · 19 mi away
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center @ Commack, Commack · 19 mi away
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
RecruitingPhase 2
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack · 19 mi away
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in East Norwalk
- Breast Cancer35 studies
- Non-Small Cell Lung Cancer18 studies
- Prostate Cancer16 studies
- Acute Myeloid Leukemia14 studies
- Multiple Myeloma13 studies
- Endometrial Cancer12 studies
- Bladder Cancer10 studies
- Lung Cancer10 studies
- Ovarian Cancer10 studies
- Cancer (all types)10 studies
- Lymphoma8 studies
- Colorectal Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.